Public Health England has reported a significant increases in new cases of scarlet fever, with the level of notifications at its highest in nearly 25 years.

Scarlet fever notifications across England reached a total of 3,548 since the season began in September 2013, compared to an average of 1,420 cases reported for the same period in the previous 10 years. The last season to have this level of scarlet fever activity was 1989/1990 when 4,042 notifications were received.
Scarlet fever is an infectious disease caused by group A streptococcus bacterium and is most common in children aged 2-8. Typically there are seasonal rises in scarlet fever between December and April each year, and also a cycle of increases and decreases in incidence that repeats over a period of several years.

Effective outbreak management
Dr Theresa Lamagni, PHE’s head of streptococcal infection surveillance, said: “The first symptoms of scarlet fever often include a sore throat, headache, fever, nausea, and vomiting. Between 12 to 48 hours after this, a characteristic rash develops. Cases are more common in children although adults can also develop scarlet fever. Symptoms usually clear up after a week and the majority of cases can be treated with a course of antibiotics to reduce risk of complications.
“PHE recommends that people with symptoms of scarlet fever see their GP.  Once children or adults are diagnosed with scarlet fever we strongly advise them to stay at home until at least 24 hours after the start of antibiotic treatment to avoid passing on the infection.
“PHE publishes guidance for schools where infections can spread easily. Where outbreaks occur, local health protection teams are on hand to provide a rapid response, effective outbreak management and authoritative advice.”

Further reading: MPs call drugs fund to support children with rare conditions

Routine monitoring of surveillance data identified widespread increases in scarlet fever notifications in February 2014 compared to recent years.

These increases continued into March and April, with weeks 10 and 11 of 2014 being particularly high with numbers of notifications surpassing levels seen in the last peak year (2008/09).  As a result of this increase in scarlet fever, PHE is alerting health practitioners so they can be mindful of the current increase when assessing patients.
There is currently no vaccine for scarlet fever but antibiotic treatment should be given to minimise the risk of complications. PHE has pledged to continue to monitor these increases and "work closely with healthcare professionals to try and halt the spread of infection".